02103nam a2200289 4500 ESSALUD 20260817144932.0 ta t pe ||||| |||| 00| 0 spa d BMG eng Cho, Hae Lin Autor 54080 Consumed with Inflammation. Clinical Problem-Solving páginas: 593-598 A 60-year-old woman with stage II triple-negative breast cancer presented to the emergency department with a weeklong history of fevers, rigors, malaise, nonproductive cough, and nausea. She reported intermittent lightheadedness, headaches, and neck pain when febrile but no sore throat, rhinorrhea, shortness of breath, vomiting, abdominal pain, or dysuria. She noted no recent travel or sick contacts. Two months before presentation, she completed neoadjuvant carboplatin, paclitaxel, and doxorubicin and then, 1 month before presentation, underwent lumpectomy of the left breast and sentinel-lymph-node biopsy. She had also been treated as part of a clinical trial with multiple cycles of pembrolizumab (first dose, 6 months before presentation; last dose, 6 days before presentation). Although she had had transient neutropenia from chemotherapy, her white-cell counts had normalized after her last cycle. Postoperatively, mild tenderness and swelling around her left axilla had developed without systemic signs of infection; computed tomographic (CT) imaging was consistent with an uncomplicated seroma. In the days leading up to this presentation, her tenderness in this area had resolved. MEDICINA CLÍNICA HOSPITALARIA 53754 CANCER DE MAMA 54081 HEMATOLOGÍA 7422 ONCOLOGÍA 12240 ENFERMEDAD INFLAMATORIA 53667 Berliner, Nancy 54082 Babcock, Stephen 54083 Sun, Yee-Ping 54084 Levy , Bruce 54085 22717 22644 Massachusetts NEJM Group NEJM009 The New England Journal of Medicine ESSALUD 0028-4793 ARTICULOS 2026-08-17 SQB 22822 22822